查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585101

全球 GMP 细胞银行服务市场：产业分析、规模、占有率、成长、趋势、预测（2024-2031）

GMP Cell Banking Service Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 164 Pages | 商品交期: 2-5个工作天内

价格
简介目录

该报告研究和分析了全球 GMP 细胞银行服务市场，深入洞察市场结构以及对市场推动因素、趋势、机会、推动因素和课题等关键市场动态的评估。

目录

第1章 内容提要

第二章 GMP细胞银行服务市场简介

第三章 GMP细胞银行服务市场分析场景

  • 市集情境预测
  • 市场及预测
    • 市场和年成长
  • 细胞银行：流程工作流程
  • 监管概述：美国 FDA 合约开发指南

第四章 GMP细胞银行服务市场动态

  • 宏观经济推动因素
  • 促进因素
    • 供给侧
    • 需求方
  • 阻碍因素
  • 机会
  • 趋势

第五章全球 GMP 细胞银行服务市场：依细胞类型

  • GMP 细胞银行服务市场占有率分析及同比分析：按细胞类型
  • GMP 细胞银行服务市场价值、年成长、绝对利润机会
    • 哺乳动物细胞类型
    • 微生物细胞类型
    • 昆虫细胞型
    • 酵母细胞类型
    • 禽类细胞类型
    • 干细胞类型
    • 其他细胞类型
  • GMP 细胞银行服务市场价值分析与预测：依细胞类型
  • GMP 细胞银行服务市场吸引力分析：依细胞类型

第六章全球 GMP 细胞银行服务市场：依最终用户分类

  • GMP 细胞银行服务市场占有率分析及同比分析：按最终用户
  • GMP 细胞银行服务市场价值、年成长、绝对利润机会
    • 生物製药公司
    • 开发合约组织
  • GMP 细胞银行服务市场价值分析与预测：按最终用户
  • GMP 细胞银行服务市场吸引力分析：按最终用户

第七章全球 GMP 细胞银行服务市场：按地区

  • GMP 细胞银行服务市场占有率分析及同比分析：按地区
  • GMP 细胞银行服务市场价值、年成长、绝对利润机会
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • GMP 细胞银行服务市值分析与预测：按地区
  • GMP 细胞银行服务市场吸引力分析：按地区

第八章北美GMP细胞银行服务市场分析

  • 北美 GMP 细胞银行服务市场占有率分析和同比增长分析：按国家/地区
  • 美国 GMP 细胞银行服务市场价值、年成长和绝对收入机会
  • 加拿大 GMP 细胞银行服务市场价值、年成长、绝对收入机会
  • 北美 GMP 细胞银行服务市场价值分析与预测：按国家/地区
    • 美国
    • 加拿大
  • 北美 GMP 细胞银行服务市场价值分析与预测：按细胞类型
    • 哺乳动物细胞类型
    • 微生物细胞类型
    • 昆虫细胞型
    • 酵母细胞类型
    • 禽类细胞类型
    • 干细胞类型
    • 其他细胞类型
  • 北美 GMP 细胞银行服务市场价值分析与预测：按最终用户
    • 生物製药公司
    • 开发合约组织
  • 北美GMP细胞银行服务市场吸引力分析
    • 按国家
    • 按细胞类型
    • 按最终用户
  • 北美：促进因素和抑制因素影响分析

第九章拉丁美洲 GMP 细胞银行服务市场分析

  • 拉丁美洲 GMP 细胞银行服务市场占有率分析和同比增长分析：按国家/地区
  • 巴西 GMP 细胞银行服务市场价值、年成长、绝对利润机会
  • 墨西哥 GMP 细胞银行服务市场价值、年成长、绝对利润机会
  • 其他拉丁美洲 GMP 细胞银行服务市场价值、年成长和绝对收入机会
  • 拉丁美洲 GMP 细胞银行服务市场价值分析与预测：按国家/地区
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 拉丁美洲 GMP 细胞银行服务市场价值分析与预测：按细胞类型
    • 哺乳动物细胞类型
    • 微生物细胞类型
    • 昆虫细胞型
    • 酵母细胞类型
    • 禽类细胞类型
    • 干细胞类型
    • 其他细胞类型
  • 拉丁美洲 GMP 细胞银行服务市场价值分析与预测：按最终用户
    • 生物製药公司
    • 开发合约组织
  • 拉丁美洲 GMP 细胞银行服务市场吸引力分析
    • 按国家
    • 按细胞类型
    • 按最终用户
  • 拉丁美洲：促进因素和抑制因素的影响分析

第十章欧洲 GMP 细胞银行服务市场分析

  • 欧洲 GMP 细胞银行服务市场占有率分析和同比增长分析：按国家/地区
  • 英国 GMP 细胞银行服务市场价值、年成长、绝对收入机会
  • 法国 GMP 细胞银行服务市场价值、年成长、绝对收入机会
  • 德国 GMP 细胞银行服务市场价值、年成长和绝对利润机会
  • 义大利 GMP 细胞银行服务市场价值、年成长和绝对利润机会
  • 西班牙 GMP 细胞银行服务市场价值、年成长和绝对利润机会
  • 俄罗斯 GMP 细胞银行服务市场价值、年成长、绝对利润机会
  • 其他欧洲 GMP 细胞银行服务市场价值、年成长和绝对收入机会
  • 欧洲 GMP 细胞银行服务市场价值分析与预测：按国家/地区
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 欧洲其他地区
  • 欧洲 GMP 细胞银行服务市场价值分析与预测：按细胞类型
    • 哺乳动物细胞类型
    • 微生物细胞类型
    • 昆虫细胞型
    • 酵母细胞类型
    • 禽类细胞类型
    • 干细胞类型
    • 其他细胞类型
  • 欧洲 GMP 细胞银行服务市场价值分析与预测：按最终用户
    • 生物製药公司
    • 开发合约组织
  • 欧洲GMP细胞银行服务市场吸引力分析
    • 按国家
    • 按细胞类型
    • 按最终用户
  • 欧洲：促进因素和抑制因素影响分析

第十一章亚太地区 GMP 细胞银行服务市场分析

  • 亚太地区 GMP 细胞银行服务市场占有率分析和年增长分析：按国家/地区
  • 日本GMP细胞银行服务市场价值、年成长及绝对利润机会
  • 中国GMP细胞银行服务市场价值、年成长、绝对获利机会
  • 印度 GMP 细胞银行服务市场价值、年成长、绝对收入机会
  • 澳洲和纽西兰 GMP 细胞银行服务市场价值、年成长和绝对利润机会
  • 东协 GMP 细胞银行服务市场价值、年成长、绝对获利机会
  • 其他亚太地区 GMP 细胞银行服务市场价值、年成长、绝对收入机会
  • 亚太地区 GMP 细胞银行服务市场价值分析与预测：按国家/地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚/纽西兰
    • ASEAN
    • 亚太其他地区
  • 亚太地区 GMP 细胞银行服务市场价值分析与预测：依细胞类型
    • 哺乳动物细胞类型
    • 微生物细胞类型
    • 昆虫细胞型
    • 酵母细胞类型
    • 禽类细胞类型
    • 干细胞类型
    • 其他细胞类型
  • 亚太地区 GMP 细胞银行服务市场价值分析与预测：按最终用户
    • 生物製药公司
    • 开发合约组织
  • 亚太地区GMP细胞银行服务市场吸引力分析
    • 按国家
    • 按细胞类型
    • 按最终用户
  • 亚太地区：促进因素和抑制因素的影响分析

第十二章中东与非洲GMP细胞银行服务市场分析

  • 中东和非洲 GMP 细胞银行服务市场占有率分析和同比增长分析：按国家/地区
  • 海湾合作委员会国家 GMP 细胞银行服务市场价值、年成长和绝对收入机会
  • 南非 GMP 细胞银行服务市场价值、年成长和绝对利润机会
  • 北非 GMP 细胞银行服务市场价值、年成长和绝对利润机会
  • 其他中东和非洲 GMP 细胞银行服务市场价值、年成长、绝对收入机会
  • 中东和非洲 GMP 细胞银行服务市场价值分析与预测：按国家/地区
    • 海湾合作委员会国家
    • 南非
    • 北非
    • 其他中东/非洲
  • 中东和非洲 GMP 细胞银行服务市场价值分析与预测：按细胞类型
    • 哺乳动物细胞类型
    • 微生物细胞类型
    • 昆虫细胞型
    • 酵母细胞类型
    • 禽类细胞类型
    • 干细胞类型
    • 其他细胞类型
  • 中东和非洲 GMP 细胞银行服务市场价值分析与预测：按最终用户
    • 生物製药公司
    • 开发合约组织
  • 中东及非洲GMP细胞银行服务市场吸引力分析
    • 按国家
    • 按细胞类型
    • 按最终用户
  • 中东和非洲：促进因素和抑制因素的影响分析

第13章 竞争格局

  • 全球 GMP 细胞银行服务市场 – 仪表板
  • 公司简介（概述、主要比率、财务状况、SWOT、策略、最新趋势）
    • WuXi AppTec
    • Charles River Laboratories International, Inc.
    • Eurofins Scientific
    • Merck KGaA
    • Lonza Group Ltd
    • SGS Ltd
    • ViruSure GmbH
    • Austrianova
    • Goodwin Biotechnology Inc.
    • Paragon Bioservices, Inc.

第14章 使用的假设和首字母缩略词

第15章 研究方法论

简介目录
Product Code: PMRREP13735

Persistence Market Research has recently released a detailed report on the global GMP (Good Manufacturing Practice) Cell Banking Service Market. The report provides an in-depth analysis of crucial market dynamics, such as key growth drivers, trends, opportunities, and challenges, offering valuable insights into the market's structure. This research publication outlines key data and statistics forecasting the growth of the GMP cell banking service market from 2024 to 2031.

Key Insights:

  • GMP Cell Banking Service Market Size (2024E): US$ 967.4 Mn
  • Projected Market Value (2031F): US$ 2,275.9 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.0%

GMP Cell Banking Service Market - Report Scope:

GMP cell banking services are vital for ensuring the production of biologics and other pharmaceutical products that require high-quality, safe, and compliant cell lines. These services involve the creation and storage of cell banks used for the production of cell-based therapies and vaccines. The GMP cell banking market is driven by the increasing demand for biopharmaceuticals, the rise in cell-based therapies, and growing regulatory requirements around the manufacturing process of biologics. Companies are investing in state-of-the-art facilities to develop and maintain GMP-compliant cell lines, which meet the highest standards of safety and efficacy. Additionally, the growing demand for personalized medicine and regenerative therapies continues to propel the market.

Market Growth Drivers:

The global GMP cell banking service market is primarily driven by the growing demand for biologics and cell-based therapies. The rapid advancements in regenerative medicine, coupled with the rising prevalence of chronic diseases, are pushing the need for quality-controlled cell lines. Increasing investments in biopharmaceutical R&D and the rising demand for personalized medicine also support market expansion. Regulatory authorities, such as the FDA and EMA, emphasize stringent compliance with GMP standards, ensuring the safety and efficacy of cell-based therapeutics. Additionally, the shift towards advanced therapies such as CAR-T cells is creating opportunities for GMP cell banking services.

Market Restraints:

Despite its robust growth, the GMP cell banking service market faces challenges such as high operational costs associated with maintaining GMP-compliant facilities and adhering to stringent regulatory standards. Moreover, the complexity of developing and storing cell lines that meet the required specifications can delay product timelines. Another challenge is the potential risk of contamination during the cell banking process, which could jeopardize the quality and safety of the final product. These factors may limit market growth in certain regions.

Market Opportunities:

The GMP cell banking service market offers significant growth opportunities, especially with the increasing focus on personalized medicine and the development of novel cell-based therapies. The introduction of automated systems in cell banking processes offers an opportunity to reduce human error, improve efficiency, and lower operational costs. Expanding research and clinical trials into new cell-based therapies like gene editing and immunotherapy presents new avenues for growth. Additionally, strategic partnerships between biotech firms and contract manufacturing organizations (CMOs) could enable faster, more cost-effective cell line development and commercialization.

Key Questions Answered in the Report:

  • What are the primary drivers contributing to the growth of the GMP cell banking service market globally?
  • Which regions are witnessing the highest demand for GMP-compliant cell lines and why?
  • How are technological innovations, such as automation and cryopreservation techniques, shaping the future of the GMP cell banking market?
  • Who are the leading players in the GMP cell banking service market, and what strategies are they using to maintain a competitive edge?
  • What are the emerging trends in the GMP cell banking service sector, and how are they expected to impact market dynamics?

Competitive Intelligence and Business Strategy:

Leading companies in the GMP cell banking service market, such as Lonza, WuXi AppTec, and Catalent, are focusing on enhancing their service offerings through innovation, geographic expansion, and strategic collaborations. These firms are investing heavily in research and development to provide advanced cell banking solutions, including optimized storage techniques and cutting-edge automation for improved operational efficiency. Key players are also establishing new facilities in strategic regions to capture growing demand in emerging markets. Sustainability initiatives and technology adoption remain central to their business strategies to stay competitive in the evolving landscape of GMP cell banking services.

Key Companies Profiled:

  • WuXi AppTec
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Lonza Group Ltd
  • SGS Ltd
  • ViruSure GmbH
  • Austrianova
  • Goodwin Biotechnology Inc.
  • Paragon Bioservices, Inc.

Market Segmentation

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

By Cell Type

  • Mammalian
  • Microbial
  • Insect
  • Yeast
  • Avian
  • Stem Cell

By End User

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations

Table of Contents

1. Executive Summary

2. GMP Cell Banking Services Market Introduction

  • 2.1. GMP Cell Banking Services Market Introduction and Definitions
  • 2.2. GMP Cell Banking Services Market Taxonomy

3. GMP Cell Banking Services Market Analysis Scenario

  • 3.1. Market Scenario (US$ Mn) Forecast
  • 3.2. Market Size (US$ Mn) and Forecast
    • 3.2.1. Market Value (US$ Mn) and Y-o-Y Growth
    • 3.2.2. Absolute $ Opportunity
  • 3.3. Cell Banking: Process Workflow
  • 3.4. Regulatory Overview: U.S. FDA Guidance on Contract Manufacturing

4. GMP Cell Banking Services Market Dynamics

  • 4.1. Macro-economic Drivers
  • 4.2. Drivers
    • 4.2.1. Supply-side
    • 4.2.2. Demand-side
  • 4.3. Restraints
  • 4.4. Opportunities
  • 4.5. Trends

5. Global GMP Cell Banking Services Market By Cell Type

  • 5.1. GMP Cell Banking Services Market Share Analysis and Y-o-Y Analysis By Cell Type, 2024-2031
  • 5.2. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
    • 5.2.1. Mammalian Cell Type
    • 5.2.2. Microbial Cell Type
    • 5.2.3. Insect Cell Type
    • 5.2.4. Yeast Cell Type
    • 5.2.5. Avian Cell Type
    • 5.2.6. Stem Cell Type
    • 5.2.7. Other Cell Type
  • 5.3. GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
  • 5.4. GMP Cell Banking Services Market Attractiveness Analysis By Cell Type, 2024-2031

6. Global GMP Cell Banking Services Market By End User

  • 6.1. GMP Cell Banking Services Market Share Analysis and Y-o-Y Analysis By End User, 2024-2031
  • 6.2. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
    • 6.2.1. Biopharmaceutical Companies
    • 6.2.2. Contract Manufacturing Organizations
  • 6.3. GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
  • 6.4. GMP Cell Banking Services Market Attractiveness Analysis By End User, 2024-2031

7. Global GMP Cell Banking Services Market By Region

  • 7.1. GMP Cell Banking Services Market Share Analysis and Y-o-Y Analysis By Region, 2024-2031
  • 7.2. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
    • 7.2.1. North America
    • 7.2.2. Latin America
    • 7.2.3. Europe
    • 7.2.4. Asia Pacific
    • 7.2.5. Middle East & Africa
  • 7.3. GMP Cell Banking Services Market Value Analysis and Forecast By Region, 2024-2031
  • 7.4. GMP Cell Banking Services Market Attractiveness Analysis By Region, 2024-2031

8. North America GMP Cell Banking Services Market Analysis

  • 8.1. North America GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
  • 8.2. U.S. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 8.3. Canada GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 8.4. North America GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. North America GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
    • 8.5.1. Mammalian Cell Type
    • 8.5.2. Microbial Cell Type
    • 8.5.3. Insect Cell Type
    • 8.5.4. Yeast Cell Type
    • 8.5.5. Avian Cell Type
    • 8.5.6. Stem Cell Type
    • 8.5.7. Other Cell Type
  • 8.6. North America GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
    • 8.6.1. Biopharmaceutical Companies
    • 8.6.2. Contract Manufacturing Organizations
  • 8.7. North America GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
    • 8.7.1.By Country
    • 8.7.2.By Cell Type
    • 8.7.3.By End User
  • 8.8. North America: Drivers and Restraints Impact Analysis

9. Latin America GMP Cell Banking Services Market Analysis

  • 9.1. Latin America GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
  • 9.2. Brazil GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 9.3. Mexico GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 9.4. Rest of Latin America GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 9.5. Latin America GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Latin America GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
    • 9.6.1. Mammalian Cell Type
    • 9.6.2. Microbial Cell Type
    • 9.6.3. Insect Cell Type
    • 9.6.4. Yeast Cell Type
    • 9.6.5. Avian Cell Type
    • 9.6.6. Stem Cell Type
    • 9.6.7. Other Cell Type
  • 9.7. Latin America GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
    • 9.7.1. Biopharmaceutical Companies
    • 9.7.2. Contract Manufacturing Organizations
  • 9.8. Latin America GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
    • 9.8.1. By Country
    • 9.8.2. By Cell Type
    • 9.8.3. By End User
  • 9.9. Latin America: Drivers and Restraints Impact Analysis

10. Europe GMP Cell Banking Services Market Analysis

  • 10.1. Europe GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
  • 10.2. U.K. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.3. France GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.4. Germany GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.5. Italy GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.6. Spain GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.7. Russia GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.8. Rest of Europe GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 10.9. Europe GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
    • 10.9.1. U.K.
    • 10.9.2. France
    • 10.9.3. Germany
    • 10.9.4. Italy
    • 10.9.5. Spain
    • 10.9.6. Russia
    • 10.9.7. Rest of Europe
  • 10.10. Europe GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
    • 10.10.1. Mammalian Cell Type
    • 10.10.2. Microbial Cell Type
    • 10.10.3. Insect Cell Type
    • 10.10.4. Yeast Cell Type
    • 10.10.5. Avian Cell Type
    • 10.10.6. Stem Cell Type
    • 10.10.7. Other Cell Type
  • 10.11. Europe GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
    • 10.11.1. Biopharmaceutical Companies
    • 10.11.2. Contract Manufacturing Organizations
  • 10.12. Europe GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
    • 10.12.1. By Country
    • 10.12.2. By Cell Type
    • 10.12.3. By End User
  • 10.13. Europe: Drivers and Restraints Impact Analysis

11. Asia Pacific GMP Cell Banking Services Market Analysis

  • 11.1. Asia Pacific GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
  • 11.2. Japan GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 11.3. China GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 11.4. India GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 11.5. Australia & New Zealand GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 11.6. ASEAN GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 11.7. Rest of Asia Pacific GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 11.8. Asia Pacific GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
    • 11.8.1. Japan
    • 11.8.2. China
    • 11.8.3. India
    • 11.8.4. Australia & New Zealand
    • 11.8.5. ASEAN
    • 11.8.6. Rest of Asia Pacific
  • 11.9. Asia Pacific GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
    • 11.9.1. Mammalian Cell Type
    • 11.9.2. Microbial Cell Type
    • 11.9.3. Insect Cell Type
    • 11.9.4. Yeast Cell Type
    • 11.9.5. Avian Cell Type
    • 11.9.6. Stem Cell Type
    • 11.9.7. Other Cell Type
  • 11.10. Asia Pacific GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
    • 11.10.1. Biopharmaceutical Companies
    • 11.10.2. Contract Manufacturing Organizations
  • 11.11. Asia Pacific GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
    • 11.11.1. By Country
    • 11.11.2. By Cell Type
    • 11.11.3. By End User
  • 11.12. Asia Pacific: Drivers and Restraints Impact Analysis

12. Middle East & Africa GMP Cell Banking Services Market Analysis

  • 12.1. Middle East & Africa GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
  • 12.2. GCC Countries GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 12.3. South Africa GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 12.4. North Africa GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 12.5. Rest of MEA GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 12.6. Middle East & Africa GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
    • 12.6.1. GCC Countries
    • 12.6.2. South Africa
    • 12.6.3. North Africa
    • 12.6.4. Rest of MEA
  • 12.7. Middle East & Africa GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
    • 12.7.1. Mammalian Cell Type
    • 12.7.2. Microbial Cell Type
    • 12.7.3. Insect Cell Type
    • 12.7.4. Yeast Cell Type
    • 12.7.5. Avian Cell Type
    • 12.7.6. Stem Cell Type
    • 12.7.7. Other Cell Type
  • 12.8. Middle East & Africa GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
    • 12.8.1. Biopharmaceutical Companies
    • 12.8.2. Contract Manufacturing Organizations
  • 12.9. Middle East & Africa GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
    • 12.9.1. By Country
    • 12.9.2. By Cell Type
    • 12.9.3. By End User
  • 12.10. Middle East & Africa: Drivers and Restraints Impact Analysis

13. Competitive Landscape

  • 13.1. Global GMP Cell Banking Services Market - Dashboard
  • 13.2. Company Profiles (Overview, Key Ratios, Financials, SWOT, Strategy, Recent Developments)
    • 13.2.1. WuXi AppTec
    • 13.2.2. Charles River Laboratories International, Inc.
    • 13.2.3. Eurofins Scientific
    • 13.2.4. Merck KGaA
    • 13.2.5. Lonza Group Ltd
    • 13.2.6. SGS Ltd
    • 13.2.7. ViruSure GmbH
    • 13.2.8. Austrianova
    • 13.2.9. Goodwin Biotechnology Inc.
    • 13.2.10. Paragon Bioservices, Inc.

14. Assumptions and Acronyms Used

15. Research Methodology